Doxercalciferol comment watch save
BreastfeedingPediatric

  • TRADE NAME: Hectorol (Genzyme)
  • INDICATIONS: Secondary hyperparathyroidism in patients with chronic kidney disease on dialysis
  • CLASS: Vitamin D receptor agonist
  • HALF-LIFE: 32–37 hours

Contra-indicated in patients with a tendency towards hypercalcemia or current evidence of vitamin D toxicity.

Please login to view the rest of this drug profile.

Page last updated 07/31/2023

Symbol key

Incidence

<1% 1‑5% 5‑10% 10‑15% 15‑20% 20‑30% >30%

Seriousness

Hospitalization possible
Life threatening
Fatal

Warnings in other populations

BreastfeedingBreast feeding

GeriatricGeriatric

PediatricPediatric

Back to top